Measuring procalcitonin (PCT) in patients with sepsis can help healthcare professionals to establish the concept of bacterial burden, safely manage antibiotics, and improve clinical and financial outcomes. Learners will review the diagnostic and treatment dilemmas associated with the management of sepsis, as well as the high-level pathophysiology, kinetics, and advantages of procalcitonin in comparison to traditional biomarkers of infection. Case studies illuminating the appropriate application of PCT for safely reducing antibiotic exposure will ground viewers in skills they can apply to their practice. Lastly, a brief analysis of clinical and financial outcomes should motivate learners to consider the use of PCT in their patient care.
- Differentiate the pathophysiology and kinetics of PCT in comparison to other biomarkers of infection.
- Establish the role of PCT in conjunction with other laboratory testing to better manage patients with sepsis.
- Translate published clinical and health economic data on expected outcomes with proper use.
Michael Broyles, Pharm.D.
Director of Medical Affairs, Biomarkers
In the rapidly evolving landscape of diagnostic testing, Siemens Healthineers recognizes the value of ongoing education for both clinicians and laboratory professionals. This webinar is part of our Clinical Experts on Demand webinar series, offering a suite of educational webinars led by industry leaders discussing how innovations in laboratory diagnostics are transforming patient care delivery.